lipodystrophy is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Fluid statics or hydrostatics is the branch of fluid mechanics that studies fluids at rest. It embraces the study of the conditions under which fluids are at rest in stable equilibrium; and is contrasted with fluid dynamics, the study of fluids in motion. Hydrostatics offers physical explanations for many phenomena of everyday life, such as why atmospheric pressure changes with altitude, why wood and oil float on water, and why the surface of water is always level whatever the shape of its container. Hydrostatics is fundamental to hydraulics, the engineering of equipment for storing, transporting and using fluids. It is also relevant to some aspects of geophysics and astrophysics (for example, in understanding plate tectonics and anomalies in the Earth's gravitational field), to meteorology, to medicine (in the context of blood pressure), and many other fields.
== Therapeutic application == Thymosin α1 is approved in some countries for the treatment of Hepatitis B and C, and it is also used to boost the immune response in the treatment of other diseases. The synthetic version of Thymosin α1 is known as Thymalfasin and is sold under the brand name Zadaxin. Thymosin α1 is usually administered by subcutaneous injection.
The "war on drugs" thus brought with it a shift from reliance on imported supplies to domestic cultivation, particularly in Hawaii and California. Beginning in 1982, the Drug Enforcement Administration turned increased attention to marijuana farms in the United States, and there was a shift to the indoor growing of plants specially developed for small size and high yield. After over a decade of decreasing use, marijuana smoking began an upward trend once more in the early 1990s, especially among teenagers, but by the end of the decade this upswing had leveled off well below former peaks of use.
=== Spectral skewing === Spectral skewing is the change in relative intensity of mass spectral peaks due to the changes in concentration of the analyte in the ion source as the mass spectrum is scanned. This situation occurs routinely as chromatographic components elute into a continuous ion source. Spectral skewing is not observed in ion trap (quadrupole (this has been seen also in QMS) or magnetic) or time-of-flight (TOF) mass analyzers because potentially all ions formed in operational cycle (a snapshot in time) of the instrument are available for detection.
Sources: en.wikipedia.org
=== Lightweight === Backpackers must carry everything with them so they require all of their gear and food to be as lightweight as possible. Campers often turn to freeze-dried and dehydrated meals and ingredients for this reason, but they will also sometimes take a pouch of tuna or some other ingredient with a high water content with them as a treat, providing that the item has nutritional value. Backpackers usually take empty containers back with them for recycling and proper disposal.
The tulip's flowers are usually large and are actinomorphic (radially symmetric) and hermaphrodite (contain both male (androecium) and female (gynoecium) characteristics), generally erect, or more rarely pendulous, and are arranged more usually as a single terminal flower, or when pluriflor as two to three (e.g. Tulipa turkestanica), but up to four, flowers on the end of a floriferous stem (scape), which is single arising from amongst the basal leaf rosette. In structure, the flower is generally cup or star-shaped. As with other members of Liliaceae the perianth is undifferentiated (perigonium) and biseriate (two whorled), formed from six free (i.e. apotepalous) caducous tepals arranged into two separate whorls of three parts (trimerous) each. The two whorls represent three petals and three sepals but are termed tepals because they are nearly identical. The tepals are usually petaloid (petal-like), being brightly coloured, but each whorl may be different, or have different coloured blotches at their bases, forming darker colouration on the interior surface. The inner petals have a small, delicate cleft at the top, while the sturdier outer ones form uninterrupted ovals. The flowers have six distinct, basifixed introrse stamens arranged in two whorls of three, which vary in length and may be glabrous or hairy. The filaments are shorter than the tepals and dilated towards their base. The style is short or absent and each stigma has three distinct lobes, and the ovaries are superior, with three chambers.
Milk ejection reflex/Letdown reflex: in lactating (breastfeeding) mothers, oxytocin acts at the mammary glands, causing milk to be 'let down' into lactiferous ducts, from where it can be excreted via the nipple. Suckling by the infant at the nipple is relayed by spinal nerves to the hypothalamus. The stimulation causes neurons that produce oxytocin to fire action potentials in intermittent bursts; these bursts result in oxytocin pulses from the neurosecretory nerve terminals of the pituitary gland. Uterine contraction: important for cervical dilation before birth, oxytocin causes contractions during the second and third stages of labor. Oxytocin release during breastfeeding causes mild but often painful contractions during the first few weeks of lactation. This also assists the uterus in clotting the placental attachment point postpartum. However, in knockout mice lacking the oxytocin receptor, reproductive behavior and birth are normal. In male rats, oxytocin may induce erections. A burst of oxytocin is released during ejaculation in several species, including human males; its suggested function is to stimulate contractions of the reproductive tract, aiding sperm release. Human sexual response: Oxytocin levels in plasma rise during sexual stimulation and orgasm. At least two uncontrolled studies have found increases in plasma oxytocin at orgasm in both men and women. Plasma oxytocin levels are increased around the time of self-stimulated orgasm and are still higher than baseline when measured five minutes after self arousal.
Coating defines the biocompatibility of the therapeutic agent and its ability to travel in the body. When the agent is not biocompatible, it will quickly be excreted from the body, and there will be magnetic accumulation or off-target therapeutic effects. The use of organic or inorganic coating molecules increases the half-life of the nanocarrier by delaying its clearance by the reticuloendothelial system (RES). This delay occurs because the coating overcomes the pH, hydrophobicity, and surface charge of the magnetic nanoparticles. Additionally, coating allows molecules to covalently bind to specific molecules, such as ligands, proteins, or antibodies, which provides binding specificity to target tissues. A common structure of coating includes the core-shell structure. In this structure, metal oxide cores are coated with biocompatible materials which allows for increased control and biocompatibility. The most common coatings used for optimum response involve the use of polysaccharides like dextran and polymers like polyethylene glycol. Furthermore, carbon coatings have proved to be biocompatible and have high capacity for absorption into cells. Even polyaniline with anti-cancer agent epirubicin can be used for tumor exploration of the brain. Polyethyleneimine has displayed high cellular accumulation and low toxicity. This coating was found to have poor pharmacokinetic properties when used alone, but with magnetic field induction, it was found to accumulate on tumors at clinically significant rates.
=== Geneva lens measure === The Geneva Lens Measure is a device used to measure curved surfaces. It is most commonly used by opticians to measure lenses but can also be used by paleontologists to estimate the life size of dinosaur eggs from shell fragments. The instrument can be used to help estimate the size of fossil eggshells by measuring their curved surfaces. Since most eggs aren't perfectly round measurements from multiple parts of the egg with varying shell curvatures may be needed to get a full idea of the egg's size. Ideally an eggshell fragment being used to estimate the full size of an egg should be more than 3 cm long. Smaller eggshell fragments are better suited to other methods of study, like the Obrig radius dial gauge. The Geneva Lens measure gives units in diopters which must be converted to the radius in millimeters. Use of the Geneva Lens Measure to estimate the size of a fossil egg was first done by Sauer on fossil ostrich eggs.
Sources: en.wikipedia.org
The Hungarian Revolution of 1956 occurred shortly after Khrushchev arranged the removal of Hungary's Stalinist leader Mátyás Rákosi. In response to a popular anti-communist uprising, the new regime formally disbanded the secret police, declared its intention to withdraw from the Warsaw Pact and pledged to re-establish free elections. The Soviet Army invaded. Thousands of Hungarians were killed and arrested, imprisoned and deported to the Soviet Union, and approximately 200,000 Hungarians fled Hungary. Hungarian leader Imre Nagy and others were executed following secret trials. From 1957 through 1961, Khrushchev openly and repeatedly threatened the West with nuclear annihilation. He claimed that Soviet missile capabilities were far superior to those of the United States, capable of wiping out any American or European city. According to John Lewis Gaddis, Khrushchev rejected Stalin's "belief in the inevitability of war," however. The new leader declared his ultimate goal was "peaceful coexistence". In Khrushchev's formulation, peace would allow capitalism to collapse on its own, as well as giving the Soviets time to boost their military capabilities, which remained for decades until Gorbachev's later "new thinking" envisioning peaceful coexistence as an end in itself rather than a form of class struggle. The events in Hungary produced ideological fractures within the communist parties of the world, particularly in Western Europe, with great decline in membership, as many in both western and socialist countries felt disillusioned by the brutal Soviet response.
October 24, 2008: Iceland Iceland receives a £1.3 billion (US$2.06 billion, €1.63 billion) bailout package from the International Monetary Fund as the first European country to require an emergency loan with the aim of stabilising the collapsed currency and strengthening the tax system as well as the nationalised banks.
The total number of people with MS was 3.1 million globally in 2024, with a diagnosed prevalence of 38 per 100,000 people. Moreover, diagnosed prevalence varies widely in different regions around the world. In Africa, there are 4 people per 100,000 diagnosed with MS, compared to South East Asia where the prevalence is 8 per 100,000, 109 per 100,000 in the Americas, and 158 per 100,000 in Europe. The higher number of cases in countries further from the equator can partially be explained by lower UV radiation and vitamin D production. However, the true difference between countries might be smaller, as richer countries have better resources for MS diagnosis. The prevalence of MS is slowly increasing, which might be explained by countries getting better at diagnosis the disease. In addition, improvements in treatment mean that people with MS live longer. MS usually appears in adults in their twenties or thirties but it can also start in childhood and in individuals older than 40. Primary progressive MS typically starts after the age of 40. Similarly to many autoimmune disorders, the disease is more common in women, and the gender gap may have grown over time. Globally it is about two to three times more common in women than in men. In children under 12, it is only slightly more common in girls than boys, while in people with primary progressive MS, who are typically older, men and women are roughly equally affected.
Mass resolution can be improved in axial MALDI-TOF mass spectrometer where ion production takes place in vacuum by allowing the initial burst of ions and neutrals produced by the laser pulse to equilibrate and to let the ions travel some distance perpendicularly to the sample plate before the ions can be accelerated into the flight tube. The ion equilibration in plasma plume produced during the desorption/ionization takes place approximately 100 ns or less, after that most of ions irrespectively of their mass start moving from the surface with some average velocity. To compensate for the spread of this average velocity and to improve mass resolution, it was proposed to delay the extraction of ions from the ion source toward the flight tube by a few hundred nanoseconds to a few microseconds with respect to the start of short (typically, a few nanosecond) laser pulse. This technique is referred to as "time-lag focusing" for ionization of atoms or molecules by resonance enhanced multiphoton ionization or by electron impact ionization in a rarefied gas and "delayed extraction" for ions produced generally by laser desorption/ionization of molecules adsorbed on flat surfaces or microcrystals placed on conductive flat surface. Delayed extraction generally refers to the operation mode of vacuum ion sources when the onset of the electric field responsible for acceleration (extraction) of the ions into the flight tube is delayed by some short time (200–500 ns) with respect to the ionization (or desorption/ionization) event.
=== Absorption refrigerators === An absorption refrigerator works differently from a compressor refrigerator, using a source of heat, such as combustion of liquefied petroleum gas, solar thermal energy or an electric heating element. These heat sources are much quieter than the compressor motor in a typical refrigerator. A fan or pump might be the only mechanical moving parts; reliance on convection is considered impractical. Other uses of an absorption refrigerator (or "chiller") include large systems used in office buildings or complexes such as hospitals and universities. These large systems are used to chill a brine solution that is circulated through the building.
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.